Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes
Renal cell carcinoma (RCC) is a malignant tumor that is characterized by the accumulation of intracellular lipid droplets. The prognostic value of fatty acid metabolism-related genes (FMGs) in RCC remains unclear. Alongside this insight, we collected data from three RCC cohorts, namely, The Cancer G...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1094657/full |
_version_ | 1811178407426260992 |
---|---|
author | Ruifeng Ding Huawei Wei Xin Jiang Liangtian Wei Mengqiu Deng Hongbin Yuan |
author_facet | Ruifeng Ding Huawei Wei Xin Jiang Liangtian Wei Mengqiu Deng Hongbin Yuan |
author_sort | Ruifeng Ding |
collection | DOAJ |
description | Renal cell carcinoma (RCC) is a malignant tumor that is characterized by the accumulation of intracellular lipid droplets. The prognostic value of fatty acid metabolism-related genes (FMGs) in RCC remains unclear. Alongside this insight, we collected data from three RCC cohorts, namely, The Cancer Genome Atlas (TCGA), E-MTAB-1980, and GSE22541 cohorts, and identified a total of 309 FMGs that could be associated with RCC prognosis. First, we determined the copy number variation and expression levels of these FMGs, and identified 52 overall survival (OS)-related FMGs of the TCGA-KIRC and the E-MTAB-1980 cohort data. Next, 10 of these genes—FASN, ACOT9, MID1IP1, CYP2C9, ABCD1, CPT2, CRAT, TP53INP2, FAAH2, and PTPRG—were identified as pivotal OS-related FMGs based on least absolute shrinkage and selection operator and Cox regression analyses. The expression of some of these genes was confirmed in patients with RCC by immunohistochemical analyses. Kaplan–Meier analysis showed that the identified FMGs were effective in predicting the prognosis of RCC. Moreover, an optimal nomogram was constructed based on FMG-based risk scores and clinical factors, and its robustness was verified by time-dependent receiver operating characteristic analysis, calibration curve analysis, and decision curve analysis. We have also described the biological processes and the tumor immune microenvironment based on FMG-based risk score classification. Given the close association between fatty acid metabolism and cancer-related pain, our 10-FMG signature may also serve as a potential therapeutic target with dual effects on ccRCC prognosis and cancer pain and, therefore, warrants further investigation. |
first_indexed | 2024-04-11T06:18:55Z |
format | Article |
id | doaj.art-c025b55329234ea08f69c0359238d6c8 |
institution | Directory Open Access Journal |
issn | 2234-943X |
language | English |
last_indexed | 2024-04-11T06:18:55Z |
publishDate | 2022-12-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Oncology |
spelling | doaj.art-c025b55329234ea08f69c0359238d6c82022-12-22T04:40:58ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-12-011210.3389/fonc.2022.10946571094657Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genesRuifeng Ding0Huawei Wei1Xin Jiang2Liangtian Wei3Mengqiu Deng4Hongbin Yuan5Department of Anesthesiology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Anesthesiology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Anesthesiology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, ChinaJiangsu Province Key Laboratory of Anesthesiology, Xuzhou Medical University, Xuzhou, ChinaDepartment of Anesthesiology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, ChinaDepartment of Anesthesiology, Changzheng Hospital, Second Affiliated Hospital of Naval Medical University, Shanghai, ChinaRenal cell carcinoma (RCC) is a malignant tumor that is characterized by the accumulation of intracellular lipid droplets. The prognostic value of fatty acid metabolism-related genes (FMGs) in RCC remains unclear. Alongside this insight, we collected data from three RCC cohorts, namely, The Cancer Genome Atlas (TCGA), E-MTAB-1980, and GSE22541 cohorts, and identified a total of 309 FMGs that could be associated with RCC prognosis. First, we determined the copy number variation and expression levels of these FMGs, and identified 52 overall survival (OS)-related FMGs of the TCGA-KIRC and the E-MTAB-1980 cohort data. Next, 10 of these genes—FASN, ACOT9, MID1IP1, CYP2C9, ABCD1, CPT2, CRAT, TP53INP2, FAAH2, and PTPRG—were identified as pivotal OS-related FMGs based on least absolute shrinkage and selection operator and Cox regression analyses. The expression of some of these genes was confirmed in patients with RCC by immunohistochemical analyses. Kaplan–Meier analysis showed that the identified FMGs were effective in predicting the prognosis of RCC. Moreover, an optimal nomogram was constructed based on FMG-based risk scores and clinical factors, and its robustness was verified by time-dependent receiver operating characteristic analysis, calibration curve analysis, and decision curve analysis. We have also described the biological processes and the tumor immune microenvironment based on FMG-based risk score classification. Given the close association between fatty acid metabolism and cancer-related pain, our 10-FMG signature may also serve as a potential therapeutic target with dual effects on ccRCC prognosis and cancer pain and, therefore, warrants further investigation.https://www.frontiersin.org/articles/10.3389/fonc.2022.1094657/fullkidney renal clear cell carcinomafatty acid metabolismprognostic signaturenomogramtumor microenvironmentcancer pain |
spellingShingle | Ruifeng Ding Huawei Wei Xin Jiang Liangtian Wei Mengqiu Deng Hongbin Yuan Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes Frontiers in Oncology kidney renal clear cell carcinoma fatty acid metabolism prognostic signature nomogram tumor microenvironment cancer pain |
title | Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes |
title_full | Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes |
title_fullStr | Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes |
title_full_unstemmed | Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes |
title_short | Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes |
title_sort | prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism related genes |
topic | kidney renal clear cell carcinoma fatty acid metabolism prognostic signature nomogram tumor microenvironment cancer pain |
url | https://www.frontiersin.org/articles/10.3389/fonc.2022.1094657/full |
work_keys_str_mv | AT ruifengding prognosisandpaindissectionofnovelsignaturesinkidneyrenalclearcellcarcinomabasedonfattyacidmetabolismrelatedgenes AT huaweiwei prognosisandpaindissectionofnovelsignaturesinkidneyrenalclearcellcarcinomabasedonfattyacidmetabolismrelatedgenes AT xinjiang prognosisandpaindissectionofnovelsignaturesinkidneyrenalclearcellcarcinomabasedonfattyacidmetabolismrelatedgenes AT liangtianwei prognosisandpaindissectionofnovelsignaturesinkidneyrenalclearcellcarcinomabasedonfattyacidmetabolismrelatedgenes AT mengqiudeng prognosisandpaindissectionofnovelsignaturesinkidneyrenalclearcellcarcinomabasedonfattyacidmetabolismrelatedgenes AT hongbinyuan prognosisandpaindissectionofnovelsignaturesinkidneyrenalclearcellcarcinomabasedonfattyacidmetabolismrelatedgenes |